Pharmacokinetic and immunogenic behavior of three recombinant human GM- CSF-EPO hybrid proteins in Cynomolgus monkeys

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 10, Issue 2, 1998, Pages 115-122

  Coscarella, Annamaria ^a   Liddi, Roberto ^a   Bach, Simona ^a   Zappitelli, Sabrina ^a   Urso, Renato ^a   Mele, Antonio ^a   De Santis, Rita ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

GM CSF EPO; Hematopoietic growth factors; Pharmacokinetics; Primate studies; Recombinant human hybrid proteins

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 3; MEN 11300; MEN 11301; MEN 11303; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CHIMERA; CONTROLLED STUDY; CROSS REACTION; ERYTHROID CELL; IMMUNOGENICITY; MONKEY; NONHUMAN; PROTEIN PURIFICATION; STEM CELL;

EID: 0031756695     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02760860     Document Type: Article

References (22)

1. Coscarella, A., Carloni, C., Liddi, R., Mauro, S., Novelli, S., Mele, A., Massella, B., Valtieri, M., and De Santis, R. (1997) Production of recombinant human GM-CSF-EPO hybrid proteins: in vitro biological characterization. Eur. J. Haematol. 59, 238-246.
2. Benedetti Panici, P., Pierelli, L., Scambia, G., Foddai, M. L., Salerno, M. G., Menichella, G., Vittori, M., Maneschi, F., Caracussi, U., Serafini, R., Leone, G., and Mancuso, S. (1997) High-dose carboplatin, etoposide, and melphan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: nonhaematologic, haematologic toxicities and role of growth factor administration. Br. J. Cancer 75, 1205-1212.
3. Khan, K. N. M., Kats, A. A., Foutan, M., Monique, M., Snook, S. S., McKearn, J. P., Alden, C. L., and Smith, P. F. (1996) Recombinant human interleukin-3 induces extramedullary hematopoiesis at subcutaneous injection sites in cynomolgus monkeys. Toxicol. Pathol. 24(4), 391-397.
4. Krumwieh, D., Weinmann, E., Siebold, B., and Seiler, F. R. (1990) Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys. Int. J. Cell. Cloning 8, 229-248.
5. Donahue, R., Wang, E., Stone, D., Kamen, R., Wong, G. G., Sehgal, P. K., Nathan, D. G., and Clark S. C. (1986) Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 321, 872-875.
6. Donahue, R., Seehra, J., Metzger, M., Lefebvre, D., Rock, B., Carbone, S., Nathan, D. G., Garnick, M., Sehgal, P. K., Laston, D., Lavallie, E., McCoy, J., Schendel, P. F., Norton, C., Turner, K., Yang, Y., and Clark, S. C. (1988) Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 241, 1820-1823.
7. Krumwied, D., Siebold, B., Weinmann, E., and Seiler, F. R. (1991) Combined effects of granulocyte-macrophage colony stimulating factor with erythropoietin in subhuman primates. Am. J. Clin. Oncol. 14, 1-4.
8. Gibaldi, M. and Perrier, D. (1982) Pharmacokinetics, 2nd ed. Marcel Dekker, New York.
9. D'Andrea, A. D., Youssoufian, H., Zon, L., Koo, J. W., and Lodish, H. (1991) The cytoplasmatic region of the erythropoietin receptor contains non overlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11, 1980-1987.
10. Lange, B., Valtieri, M., Santoli, D., Caracciolo, D., Mavilio, F., Gemperlin, I., Griffin, C., Emanuel, B., Finan, J., Nowell, P., et al. (1987) Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 70, 192-199.
11. George, J., Bracco, C., Shannon, K., Davis, J., Smith, I. L., Phibbs, R. H., and Hendrickx, A. G. (1990) Age-related differences in erythropoietic response to recombinant human erythropoietin: comparison in adult and infant rhesus monkeys. Pediatric Res. 28, 567-571.
12. Coscarella, A., Liddi, R., Di Loreto, M., Bach, S., Faiella, A., van der Meide, P. H., Mele, A., and De Santis, R. (1998) The rhGM-CSF-EPO hybrid protein MEN 11300 induces anti-EPO antibodies and severe anemia in rhesus monkeys. Cytokine, in press.
13. Goochee, C. H., Gramer, M., Andersen, D., Bahr, J., and Rasmussen, J. (1991) The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Biotechnology 9, 1347-1355.
14. Quakyi, I. A., Miller, L. H., Good, M. F., Ahlers, J. D., Isaacs, S. N., Nunberg, J. H., Houghte, R. A., Keister, D. B., Coligan, J. E., Moss, B., et al. (1995) Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25. Pept. Res. 8, 335-344.
15. Jones, T., Stern, A., and Lin, R. (1994) Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant. Eur. J. Clin. Microbiol. Infect. Dis. 13, 47-53.
16. Tao, M. H. and Levy, R. (1993) Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362, 755-758.
17. Hopp, T. H. and Woods, K. (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. 78, 3824-3828.
18. Amoresano, A., Andolfo, A., Siciliano, R. A., Mele, A., Coscarella, A., De Santis, R., Mauro, S., Pucci, P., and Marino, G. (1998) Structural characterization and independent folding of a chimeric glycoprotein comprising Granulocyte-Macrophage Colony Stimulating Factor and Erythropoietin sequences. Glycobiology 8, 779-790.
19. Vadhan-Raj, S., Papadopoulos, N. E., Burgess, M., Linke, K. A., Patel, S. R., Hays, C., Arcenas, A., Plager, C., Kudela, A. P., Hittelman, W. N., Broxmeyer, H. E., Williams, D. P., Garrison, L., and Benjamin, R. S. (1994) Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J. Clin. Oncol. 12, 715-724.
20. Vadhan-Raj, S., Broxmeyer, H., Andreeff, M., Bandres, J. C., Buescher, E. S., Benjamin, R. S., Papadopoulos, N. E., Burgess, A., Patel, S., Plager, C., Hittelman, W. N., McAlister, I., Garrison, L., and Williams, D. E. (1995) In vivo biological effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study. Blood 86, 2098-2105.
21. O'Shaughnessy, J. A., Tolcher, A., Riseberg, D., Venzon, D., Zujewski, J. A., Noone, M., Gossard, M., Danforth, D., Jacobson, J., Chang, V., Goldspiel, B., Keegan, P., Giusti, R., and Cowan K. H. (1996) Prospective, randomized trial of 5-Fluorouracil, Leucovorin, Doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/ GM-CSF fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancer. Blood 87, 2205-2211.
22. Wen, D., Boissel, J. P. R., Tracy, T. E., Gruninger, R. H., Mulcahy, L. S., Czelusniak, J., Goodman, M., and Bunn, H. F. (1993) Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 82, 1507-1576.